A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2004 • 11,185 citations

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

2009 • 7,749 citations

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer

2009 • 1,314 citations

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

2009 • 798 citations

Cancer genomics: from discovery science to personalized medicine

2011 • 602 citations

Risks and Benefits of Phase 1 Oncology Trials, 1991 through 2002

2005 • 420 citations

An In vivo Platform for Translational Drug Development in Pancreatic Cancer

2006 • 407 citations

Clinical Cancer Advances 2008: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American Society of Clinical Oncology

2008 • 289 citations

Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer

2010 • 243 citations

KRAS Mutations and Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Colorectal Cancer: Practical Application of Patient Selection

2009 • 212 citations

Patient-Derived First Generation Xenografts of Non–Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy

2010 • 178 citations

Antitumor Effects and Biomarkers of Activity of AZD0530, a Src Inhibitor, in Pancreatic Cancer

2009 • 86 citations

Gene Expression Profiling of the Irinotecan Pathway in Colorectal Cancer

2005 • 54 citations

Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts

2009 • 42 citations